ExpreS2ion’s Chief Executive Officer, Dr. Steen Klysner, Speaks at Investordagen in Aarhus, Denmark – June 13


Horsholm, Denmark, June 8, 2017 – Today, ExpreS2ion Biotechnologies ApS (“ExpreS2ion”), a fully owned subsidiary of ExpreS2ion Biotech Holding AB, announces that its Chief Executive Officer, Dr. Steen Klysner, is speaking at Investordagen in Aarhus, Denmark on June 13th, 2017.

The event is an arrangement by Dansk Aktionærforening, with expected attendance from more than 1500 investors/shareholders.

All presentations will be available for viewing – for more information, see http://www.shareholders.dk/investordagen

For further information, please contact:
ExpreS2ion Biotechnologies
Telephone: +45 4256 6869
E-mail: info@expres2ionbio.com


About ExpreS2ion
ExpreS2ion Biotechnologies ApS, is a fully owned Danish subsidiary of ExpreS2ion Biotech Holding AB with company register number 559033-3729. The subsidiary has developed a unique platform technology, ExpreS2, enabling cost effective development and robust production of complex proteins for new vaccines and diagnostics for e.g. Malaria and Zika. Since founded in 2010, the company has used its patented ExpreS2 platform to produce more than 200 proteins in collaborations with research institutions and biopharmaceutical companies, with a superior efficiency and success rate.